Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.

导出 OA

翻译打印收藏纠错

第一作者： Juliette,Mouries

第一单位： Humanitas Clinical and Research Center - IRCCS -, via Manzoni 56, 20089 Rozzano, MI, Italy.

作者： Juliette,Mouries ^[1] ; Paola,Brescia ^[1] ; Alessandra,Silvestri ^[1] ; Ilaria,Spadoni ^[2] ; Marcel,Sorribas ^[3] ; Reiner,Wiest ^[4] ; Erika,Mileti ^[5] ; Marianna,Galbiati ^[6] ; Pietro,Invernizzi ^[6] ; Luciano,Adorini ^[7] ; Giuseppe,Penna ^[8] ; Maria,Rescigno ^[9]

作者单位： Humanitas Clinical and Research Center - IRCCS -, via Manzoni 56, 20089 Rozzano, MI, Italy. ^[1] Humanitas University, Department of Biomedical Sciences, Via Rita Levi Montalcini, 20090 Pieve Emanuele, MI, Italy. ^[2] Maurice Müller Laboratories, Department for Biomedical Research, University of Bern, Bern, Switzerland. ^[3] Maurice Müller Laboratories, Department for Biomedical Research, University of Bern, Bern, Switzerland; Department of Visceral Surgery and Medicine, Bern University Hospital, University of Bern, Bern, Switzerland. ^[4] European Institute of Oncology, Department of Experimental Oncology, 20139 Milan, MI, Italy. ^[5] Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milan-Bicocca, Milan, MI, Italy. ^[6] Intercept Pharmaceuticals, New York, NY 10014, USA. ^[7] Humanitas Clinical and Research Center - IRCCS -, via Manzoni 56, 20089 Rozzano, MI, Italy; Postbiotica srl, Via Rita Levi Montalcini, 20090 Pieve Emanuele, MI, Italy. ^[8] Humanitas Clinical and Research Center - IRCCS -, via Manzoni 56, 20089 Rozzano, MI, Italy; Humanitas University, Department of Biomedical Sciences, Via Rita Levi Montalcini, 20090 Pieve Emanuele, MI, Italy. Electronic address: maria.rescigno@hunimed.eu. ^[9]